{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T03:51:23Z","timestamp":1768881083416,"version":"3.49.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.ygyno.2014.12.001","type":"journal-article","created":{"date-parts":[[2014,12,8]],"date-time":"2014-12-08T18:21:11Z","timestamp":1418062871000},"page":"341-347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Metformin and the risk of endometrial cancer: A population-based cohort study"],"prefix":"10.1016","volume":"136","author":[{"given":"Emily M.","family":"Ko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Til","family":"St\u00fcrmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Liern","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy Camelo","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Bae-Jump","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele Jonsson","family":"Funk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2014.12.001_bb0005","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2337\/dc08-9025","article-title":"Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"32","author":"Nathan","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ygyno.2014.12.001_bb0010","series-title":"FDA approved drug products: glucophage","year":"2010"},{"key":"10.1016\/j.ygyno.2014.12.001_bb0015","series-title":"Metformin: drug Information","article-title":"Lexi-Comp","year":"2010"},{"key":"10.1016\/j.ygyno.2014.12.001_bb0020","doi-asserted-by":"crossref","first-page":"386","DOI":"10.7326\/0003-4819-147-6-200709180-00178","article-title":"Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus","volume":"147","author":"Bolen","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ygyno.2014.12.001_bb0025","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ygyno.2014.12.001_bb0030","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1210\/jc.2008-0772","article-title":"Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions","volume":"93","author":"Ratner","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ygyno.2014.12.001_bb0035","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/GRF.0b013e31802f35a0","article-title":"Pharmacologic therapy of polycystic ovary syndrome","volume":"50","author":"Dronavalli","year":"2007","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2014.12.001_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/er.2008-0030","article-title":"Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review","volume":"30","author":"Palomba","year":"2009","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ygyno.2014.12.001_bb0045","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1158\/2159-8290.CD-12-0263","article-title":"Investigating metformin for cancer prevention and treatment: the end of the beginning","volume":"2","author":"Pollak","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ygyno.2014.12.001_bb0050","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2407-11-20","article-title":"Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals","volume":"11","author":"Lee","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ygyno.2014.12.001_bb0055","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0140-6736(09)61969-3","article-title":"Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study","volume":"375","author":"Currie","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2014.12.001_bb0060","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.2337\/dc08-2175","article-title":"New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes","volume":"32","author":"Libby","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ygyno.2014.12.001_bb0065","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1053\/j.gastro.2009.04.013","article-title":"Antidiabetic therapies affect risk of pancreatic cancer","volume":"137","author":"Li","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ygyno.2014.12.001_bb0070","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1478-3231.2010.02223.x","article-title":"Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease","volume":"30","author":"Donadon","year":"2010","journal-title":"Liver Int"},{"key":"10.1016\/j.ygyno.2014.12.001_bb0075","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.3748\/wjg.15.2506","article-title":"Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease","volume":"15","author":"Donadon","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ygyno.2014.12.001_bb0080","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1002\/cncr.24982","article-title":"Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma","volume":"116","author":"Hassan","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2014.12.001_bb0085","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.2337\/dc09-1791","article-title":"Long-term metformin use is associated with decreased risk of breast cancer","volume":"33","author":"Bodmer","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ygyno.2014.12.001_bb0090","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1158\/1055-9965.EPI-10-0817","article-title":"Metformin and incident breast cancer among diabetic women: a population-based case-control study in Denmark","volume":"20","author":"Bosco","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ygyno.2014.12.001_bb0095","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s10552-009-9407-y","article-title":"Metformin use and prostate cancer in Caucasian men: results from a population-based case\u2013control study","volume":"20","author":"Wright","year":"2009","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ygyno.2014.12.001_bb0100","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cllc.2011.10.002","article-title":"Antidiabetes drugs correlate with decreased risk of lung cancer: a population-based observation in Taiwan","volume":"13","author":"Lai","year":"2012","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ygyno.2014.12.001_bb0105","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.2337\/dc12-0788","article-title":"Metformin and the risk of cancer: time-related biases in observational studies","volume":"35","author":"Suissa","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ygyno.2014.12.001_bb0110","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ygyno.2013.11.021","article-title":"Metformin is associated with improved survival in endometrial cancer","volume":"132","author":"Ko","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2014.12.001_bb0115","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ygyno.2013.10.026","article-title":"Metformin use and endometrial cancer survival","volume":"132","author":"Nevadunsky","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.12.001_bb0120","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ygyno.2013.10.026","article-title":"Metformin use and endometrial cancer survival","volume":"132","author":"Nevadunsky","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.12.001_bb0125","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/AOG.0b013e3182393ab3","article-title":"Relationship of type II diabetes and metformin use to ovarian cancer progression, survival, and chemosensitivity","volume":"119","author":"Romero","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2014.12.001_bb0130","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/ijc.22260","article-title":"Body size in relation to cancer of the uterine corpus in 1 million Norwegian women","volume":"120","author":"Bjorge","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2014.12.001_bb0135","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1158\/1055-9965.EPI-06-0751","article-title":"Diabetes and risk of endometrial cancer: a population-based prospective cohort study","volume":"16","author":"Friberg","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ygyno.2014.12.001_bb0140","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s00125-007-0681-5","article-title":"Diabetes mellitus and risk of endometrial cancer: a meta-analysis","volume":"50","author":"Friberg","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.ygyno.2014.12.001_bb0145","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1158\/1055-9965.EPI-07-2567","article-title":"Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype","volume":"17","author":"McCullough","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ygyno.2014.12.001_bb0150","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1200\/JCO.2012.48.2596","article-title":"Type I and II endometrial cancers: have they different risk factors?","volume":"31","author":"Setiawan","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2014.12.001_bb0155","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/IGC.0b013e31827b8430","article-title":"The role of preexisting diabetes mellitus on incidence and mortality of endometrial cancer: a meta-analysis of prospective cohort studies","volume":"23","author":"Zhang","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2014.12.001_bb0160","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.metabol.2013.01.014","article-title":"Metformin and sulfonylureas in relation to cancer risk in type II diabetes patients: a meta-analysis using primary data of published studies","volume":"62","author":"Thakkar","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.ygyno.2014.12.001_bb0165","article-title":"Are sulfonylurea and insulin therapies associated with a larger risk of cancer than metformin therapy? A retrospective database analysis","author":"Kowall","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ygyno.2014.12.001_bb0170","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2337\/dc11-0857","article-title":"Lower risk of cancer in patients on metformin in comparison with those on sulfonylurea derivatives: results from a large population-based follow-up study","volume":"35","author":"Ruiter","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ygyno.2014.12.001_bb0175","series-title":"Truven health analytics: marketscan research databases","year":"2013"},{"key":"10.1016\/j.ygyno.2014.12.001_bb0180","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/aje\/kwg231","article-title":"Evaluating medication effects outside of clinical trials: new-user designs","volume":"158","author":"Ray","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ygyno.2014.12.001_bb0185","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s10552-007-0131-1","article-title":"Agreement of diagnosis and its date for hematologic malignancies and solid tumors between medicare claims and cancer registry data","volume":"18","author":"Setoguchi","year":"2007","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ygyno.2014.12.001_bb0190","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1200\/JCO.2013.54.2258","article-title":"Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: American Society of Clinical Oncology clinical practice guideline focused update","volume":"32","author":"Burstein","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2014.12.001_bb0195","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial","volume":"291","author":"Anderson","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2014.12.001_bb0200","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"2","key":"10.1016\/j.ygyno.2014.12.001_bb0205","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ygyno.2014.05.018","article-title":"Endometrial cancer: a review and current management strategies: part I","volume":"134","author":"Burke","year":"2014","journal-title":"Gynecol Oncol Aug"},{"key":"10.1016\/j.ygyno.2014.12.001_bb0210","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","article-title":"The central role of the propensity score in observational studies for causal effects","volume":"70","author":"Rosenbaum","year":"1983","journal-title":"Biometrika"},{"key":"10.1016\/j.ygyno.2014.12.001_bb0215","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/aje\/kwq198","article-title":"Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution\u2014a simulation study","volume":"172","author":"Sturmer","year":"2010","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ygyno.2014.12.001_bb0220","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ygyno.2013.03.009","article-title":"Metformin and the risk of endometrial cancer: a case\u2013control analysis","volume":"129","author":"Becker","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.12.001_bb0225","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/bjc.2014.407","article-title":"Association between diabetes, diabetes treatment and risk of developing endometrial cancer","volume":"111","author":"Luo","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2014.12.001_bb0230","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1007\/s00125-012-2653-7","article-title":"Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials","volume":"55","author":"Stevens","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.ygyno.2014.12.001_bb0235","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.metabol.2011.05.002","article-title":"Incidence of malignancies in patients with diabetes mellitus and correlation with treatment modalities in a large Israeli health maintenance organization: a historical cohort study","volume":"60","author":"Buchs","year":"2011","journal-title":"Metab Clin Exp"},{"key":"10.1016\/j.ygyno.2014.12.001_bb0240","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1007\/s00125-009-1440-6","article-title":"The influence of glucose-lowering therapies on cancer risk in type 2 diabetes","volume":"52","author":"Currie","year":"2009","journal-title":"Diabetologia"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814015546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814015546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,18]],"date-time":"2019-08-18T07:37:37Z","timestamp":1566113857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825814015546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0090825814015546"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2014.12.001","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metformin and the risk of endometrial cancer: A population-based cohort study","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2014.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}